Effects of structure and modification on sustained release properties of starches

Carbohydrate Polymers

Volumn 76, Issue 4, 2009, Pages 541-547

  Onofre, Fernanda ^a   Wang, Ya Jane ^a   Mauromoustakos, Andronikos ^a  

^a UNIVERSITY OF ARKANSAS   (United States)

Author keywords

Cross linking; Starch; Substitution; Sustained release; Tablets

Indexed keywords

CHEMICAL MODIFICATION; CROSSLINKING; SUGAR (SUCROSE);

AMINOETHYL GROUPS; CARBOXYMETHYL; EPICHLOROHYDRIN; HYLON VII; LOW LEVELS; MATRIXES; MODIFIED STARCHES; POTATO STARCHES; SUBSTITUTION; SUSTAINED RELEASE; TABLETS; WAXY CORN STARCHES; WAXY CORNS;

STARCH;

SOLANUM TUBEROSUM; ZEA MAYS;

EID: 63149092221     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2008.11.016     Document Type: Article

References (56)

1. American Association of Cereal Chemists (AACC). (1997). Approved methods of the American Association of Cereal Chemists. Method 46-13.
2. Bagley E.B., and Christianson D.D. Swelling capacity of starch and its relationship to suspension viscosity - effect of cooking time, temperature, and concentration. Journal of Texture Studies 13 (1982) 115-126
3. Baille W.E., Malveau C., Zhu X.X., and Marchessault R.H. NMR imaging of high-amylose starch tablets. 1: Swelling and water uptake. Biomacromolecules 3 (2002) 214-218
4. Bettini R., Catellani P.L., Santi P., Massimo G., Peppas N.A., and Colombo P. Translocation of drug particles in HPMC matrix gel layer: Effect of drug solubility and influence on release rate. Journal of Controlled Release 70 (2001) 383-391
5. Bhattacharyya D., Singhal R.S., and Kulkarni P.R. A comparative account of conditions for synthesis of sodium carboxymethyl starch from corn and amaranth starch. Carbohydrate Polymers 27 (1995) 247-253
6. Calinescu C., Mulhbacher J., Nadeau E., Fairbrother J.M., and Mateescu M.A. Carboxymethyl high amylose starch (CM-HAS) as excipient for Escherichia coli oral formulations. European Journal of Pharmaceutics and Biopharmaceutics 60 (2005) 53-60
7. Chebli C., Cartilier L., and Hartman N.G. Substituted amylose as a matrix for sustained-drug release: A biodegradation study. International Journal of Pharmaceutics 222 (2001) 183-189
8. Chien Y.W. Concepts and system design for rate-controlled drug delivery. In: Chien Y.W. (Ed). Novel drug delivery systems (1992), Marcel Dekker, New York, NY 1-42
9. 13C] glucose microspheres as a model for drug delivery to the colon. Journal of Controlled Release 40 (1996) 123-131
10. Désévaux C., Dubreuil P., Lenaerts V., and Girard C. Tissue reaction and biodegradation of implanted cross-linked high amylose starch in rats. Journal of Biomedical Materials Research 63 (2002) 772-779
11. Dumoulin Y., Alex S., Szabo P., Cartilier L., and Mateescu M.A. Cross-linked amylose as matrix for drug controlled release. X-ray and FT-IR structural analysis. Carbohydrate Polymers 37 (1998) 361-370
12. Hebeish A., and Khalil M.I. Chemical factors affecting preparation of carboxymethyl starch. Starch/Starke 40 (1988) 147-150
13. Herman J., and Remon J.P. Modified starches as hydrophilic matrices for controlled oral delivery. II: In vitro drug release evaluation of thermally modified starches. International Journal of Pharmaceutics 56 (1989) 65-70
14. Herman J., Remon J.P., and De Vilder J. Modified starches as hydrophilic matrices for controlled oral delivery. I: Production and characterization of thermally modified starches. International Journal of Pharmaceutics 56 (1989) 51-63
15. Ispas-Szabo P., Ravenelle F., Hassan I., Preda M., and Mateescu M.A. Structure-properties relationship in cross-linked high-amylose starch for use in controlled drug release. Carbohydrate Research 323 (2000) 163-175
16. Jane J., Xu A., Radosavljevic M., and Seib P.A. Location of amylose in normal starch granules. I. Susceptibility of amylose and amylopectin to cross-linking reagents. Cereal Chemistry 69 (1992) 405-409
17. Jeon Y.-S., Viswanathan A., and Gross R.A. Studies of starch esterification: Reactions with alkenyl-succinates in aqueous slurry systems. Starch/Starke 51S (1999) 90-93
18. JMP 7.0.2. (2007). SAS Institute Inc. Cary, North Carolina, USA.
19. Kalichevsky M.T., and Ring S.G. Incompatibility of amylose and amylopectin in aqueous solution. Carbohydrate Research 162 (1987) 323-328
20. Khalil M.I., Hashem A., and Hebeish A. Carboxymethylation of maize starch. Starch/Starke 42 (1990) 60-63
21. Khalil M.I., Hashem A., and Hebeish A. Preparation and characterization of starch acetate. Starch/Starke 47 (1995) 394-398
22. Kuakpetoon D., and Wang Y.-J. Characterization of different starches oxidized by hypochlorite. Starch/Starke 53 (2001) 211-218
23. Kuakpetoon D., and Wang Y.-J. Locations of hypochlorite oxidation in corn starches varying in amylose content. Carbohydrate Research 343 (2008) 90-100
24. Landerito N.A., and Wang Y.-J. Preparation and properties of starch phosphates using waxy, common, and high-amylose corn starches. I. Oven-heating method. Cereal Chemistry 82 (2005) 215-264
25. Langer R. Polymer-controlled drug delivery systems. Accounts of Chemical Research 26 (1993) 537-542
26. Le Bail P., Morin F.G., and Marchessault R.H. Characterization of a crosslinked high amylose starch excipient. International Journal of Biological Macromolecules 26 (1999) 193-200
27. Lenaerts, V., Beck, R. H. F., Van Bogaert, E., Chouinard, F., Höpcke, R., & Désévaux, C. (2003). Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture. US Patent Office, Pat. No. 6 607 748.
28. Lenaerts V., Moussa I., Dumoulin Y., Mebsout F., Chouinard F., Szabo P., Mateescu M.A., Cartilier L., and Marchessault R.H. Cross-linked amylose starch for controlled release of drugs: Recent advances. Journal of Controlled Release 53 (1998) 225-234
29. Levina M., and Rajabi-Siahboomi A.R. The influence of excipients on drug release from hydroxypropyl methylcellulose matrices. Journal of Pharmaceutical Sciences 93 (2004) 2746-2754
30. Lidner D.W., Möeckel J.E., and Lippold B.C. Controlled release of drugs from hydrocolloid embeddings. Pharmazie 51 (1996) 263-272
31. Lordi N.G. Sustained release dosage forms. In: Lachman L., Lieberman H.A., and Kanig J.L. (Eds). The theory and practice of industrial pharmacy (1986), Lea & Febiger, Philadelphia, PA 430-456
32. Mateescu, M. A., Lenaerts, V., & Dumoulin, Y. (1995). Cross-linked material for controlled release of biologically active compounds. US Patent Office, Pat. No. 5 618 650.
33. Michailova V., Titeva S., Kotsilkova R., Krusteva E., and Minkov E. Influence of hydrogel structure on the processes of water penetration and drug release from mixed hydroxypropylmethyl cellulose/thermally pregelatinized waxy maize starch hydrophilic matrices. International Journal of Pharmaceutics 222 (2001) 7-17
34. Milojevic S., Newton J.M., Cummings J.H., Gibson G.R., Botham R.L., Ring S.G., Stockham M., and Allwood M.C. Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using 5-aminosalicylic acid pellets. Journal of Controlled Release 38 (1996) 75-84
35. Mulhbacher J., Ispas-Szabo P., Lenaerts V., and Mateescu M.A. Cross-linked high amylose starch derivatives as matrices for controlled release of high drug loadings. Journal of Controlled Release 76 (2001) 51-58
36. Mulhbacher J., Ispas-Szabo P., and Mateescu M.A. Cross-linked high amylose starch derivatives for drug release. II: Swelling properties and mechanistic study. International Journal of Pharmaceutics 278 (2004) 231-238
37. Mulhbacher J., and Mateescu M.A. Cross-linked high amylose starch derivatives for drug release. III: Diffusion properties. International Journal of Pharmaceutics 297 (2005) 22-29
38. Mundargi R.C., Shelke N.B., Rokhade A.P., Patil S.A., and Aminabhavi T.M. Formulation and in-vitro evaluation of novel starch-based tableted microspheres for controlled release of ampicillin. Carbohydrate Polymers 71 (2008) 42-53
39. Nabais T., Brouillet F., Kyriacos S., Mroueh M., da Silva P.A., Bataille B., Chebli C., and Cartilier L. High-amylose carboxymethyl starch matrices for oral sustained drug-release: In vitro and in vivo evaluation. European Journal of Pharmaceutics and Biopharmaceutics 65 (2007) 371-378
40. Pringels E., Ameye D., Vervaet C., Foreman P., and Remon J.P. Starch/Carbopol spray-dried mixtures as excipients for oral sustained drug delivery. Journal of Controlled Release 103 (2005) 635-641
41. Rahmouni M., Chouinard F., Nekka F., Lenaerts V., and Leroux J.C. Enzymatic degradation of cross-linked high amylose starch tablets and its effect on in vitro release of sodium diclofenac. European Journal of Pharmaceutics and Biopharmaceutics 51 (2001) 191-198
42. Rahmouni M., Lenaerts V., and Leroux J.-C. Drug permeation through a swollen cross-linked amylose starch membrane. S.T.P. Pharma Sciences 13 (2003) 341-348
43. Rakhmatullin R.R., Emelyushin R.E., and Gavrilov V.I. Kinetics and mechanism of reaction of sodium arsenite with chloroacetic acid in aqueous alkalis. Russian Journal of General Chemistry 69 (1999) 1389-1390
44. Ravenelle F., Marchessault R.H., Légaré A., and Buschmann M.D. Mechanical properties and structure of swollen crosslinked high amylose starch tablets. Carbohydrate Polymers 47 (2002) 259-266
45. Siew L.F., Basit A.W., and Newton M. The potential of organic-based amylose-ethylcellulose film coatings as oral colon-specific drug delivery systems. AAPS PharmSciTech 1 (2000) E22
46. Song X., He G., Ruan H., and Chen Q. Preparation and properties of octenyl succinic anhydride modified early Indica rice starch. Starch/Starke 58 (2006) 109-117
47. Takeda Y., Hizukuri S., Takeda C., and Suzuki A. Structures of branched molecules of amylose of various origins, and molar fractions of branched and unbranched molecules. Carbohydrate Research 165 (1987) 139-145
48. Takeda Y., Shirasaka K., and Hizukuri S. Examination of the purity and structure of amylose by gel-permeation chromatography. Carbohydrate Research 132 (1984) 83-92
49. Te Wierik G.H.P., Bergsma J., Arends-Scholte A.W., Boersma T., Eissens A.C., and Lerk C.F. A new generation of starch products as excipient in pharmaceutical tablets. I: Preparation and binding properties of high surface area potato starch products. International Journal of Pharmaceutics 134 (1996) 27-36
50. Te Wierik G.H.P., Eissens A.C., Bergsma J., Arends-Scholte A.W., and Lerk C.F. A new generation of starch products as excipient in pharmaceutical tablets. II. High surface area retrograded pregelatinized potato starch products in sustained-release tablets. Journal of Controlled Release 45 (1997) 25-33
51. Thérien-Aubin H., Baille W.E., Zhu X.X., and Marchessault R.H. Imaging of high-amylose starch tablets. 3: Initial diffusion and temperature effects. Biomacromolecules 6 (2005) 3367-3372
52. Tolstoguzov V. Thermodynamic considerations of starch functionality in foods. Carbohydrate Polymers 51 (2003) 99-111
53. United States Pharmacopeia/National Formulary (USP) (USP28-NF23). (2005).
54. Vilivalam V.D., Illum L., and Iqbal K. Starch capsules: An alternative system for oral drug delivery. Pharmaceutical Science Technology Today 3 (2000) 64-69
55. Vlachou M., Naseef H., and Efentakis M. Image analysis studies of dimensional changes in swellable hydrophilic polymer matrices. Polymers for Advanced Technologies 15 (2004) 683-689
56. Zhao Z.-J., Wang Q., and Zhang L. Size effect on competition of two diffusion mechanisms for drug molecules in amorphous polymers. Journal of Physical Chemistry B 111 (2007) 13167-13172